|
[1]
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209 − 49. http://dx.doi.org/10.3322/caac.21660CrossRef
|
|
[2]
|
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11(3):249 − 57. http://dx.doi.org/10.1016/S1470-2045(09)70360-2CrossRef
|
|
[3]
|
World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine 2017;35(43):5753 − 5. http://dx.doi.org/10.1016/j.vaccine.2017.05.069CrossRef
|
|
[4]
|
Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202(12):1789 − 99. http://dx.doi.org/10.1086/657321CrossRef
|
|
[5]
|
Chen X, Xu HO, Xu WW, Zeng WJ, Liu JW, Wu Q, et al. Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015. Sci Rep 2017;7(1):14813. http://dx.doi.org/10.1038/s41598-017-13299-yCrossRef
|
|
[6]
|
Guo CL, Du H, Belinson JL, Wang C, Huang X, Qu XF, et al. The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women. Infect Agent Cancer 2021;16(1):21. http://dx.doi.org/10.1186/s13027-021-00360-9CrossRef
|
|
[7]
|
Jing LP, Zhong XM, Zhong ZY, Huang WH, Liu Y, Yang G, et al. Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis 2014;41(12):732 − 8. http://dx.doi.org/10.1097/OLQ.0000000000000201CrossRef
|
|
[8]
|
Wu P, Xiong HG, Yang M, Li L, Wu P, Lazare C, et al. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: a large population-based study. Gynecol Oncol 2019;155(3):436 − 43. http://dx.doi.org/10.1016/j.ygyno.2019.10.003CrossRef
|
|
[9]
|
Ren WH, Zhao XL, Zhao FH. Global guidelines for cervical cancer screening: a systematic review. Natl Med J China 2021;101:1882 − 9. http://dx.doi.org/10.3760/cma.j.cn112137-20210115-00134 (In Chinese). CrossRef
|